Cancer BiologybioRxivPreprint
Myeloid cell-mediated killing of B-ALL by CD38 and CD20IgA antibody variants is enhanced by CD47/SIRPα interference
Maja Kowol, Marta Lustig, Annette M. Hartmann…·Thomas Valerius
This study evaluates the efficacy of CD38 and CD20 IgG1/IgA2 antibodies in mediating myeloid cell-mediated killing of B-ALL, showing enhanced activity with CD47/SIRPα blockade.
1 citation